Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection

AIM: To estimate neutralizing antibody (NAb) immunity against SARS-CoV-2 in 739 healthcare personnel (HCP) vaccinated with three doses of BNT162b2 mRNA vaccine. METHODS: Serum samples were collected at 3, 6, and 9 months after the second vaccine dose and at 7–55 days after the third dose. Samples we...

Descripción completa

Detalles Bibliográficos
Autores principales: Psaridi, Loukia, Maltezou, Helena C., Simonidou, Sofia, Lialliou, Ioanna, Athanasopoulou, Despina, Haila, Zoi, Kyrimi, Areti, Giannopoulou, Ioanna, Giannousa, Styliani, Pseimada, Maria, Christofilea, Olympia, Dounias, George, Lanitis, Sophocles, Kremasmenou, Eirini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388445/
https://www.ncbi.nlm.nih.gov/pubmed/36008235
http://dx.doi.org/10.1016/j.vaccine.2022.08.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388445/
https://www.ncbi.nlm.nih.gov/pubmed/36008235
http://dx.doi.org/10.1016/j.vaccine.2022.08.031

Ejemplares similares